Dr. Dina M. ElKhashab

• DHA, DOH, MOH Consultant Clinical Pathology and Laboratory Director with more than 19-year experience in hospitals and standalone laboratories including 12 years in UAE. Has Doctorate Degree/MD- PhD in Clinical Pathology, National cancer Institute, Cairo University, Assistant Professor of Microbiology, Clinical Pathology Department, NCI, Cairo University and EIAC Certified Internal Auditor 15189:2012. ISO 15189:2022.
• A highly motivated professional with excellent managerial skills and a strong technical background. Demonstrates decision-making competency, effective networking with patients and physicians, and resource management expertise. Proven ability to work cooperatively with the Chief Executive Officer to ensure high-quality service in a cost-effective manner. Skilled in teaching, mentoring, and empowering large teams while prioritizing commitments and delegating tasks efficiently.
• Experienced in overseeing all facets of laboratory operations, from strategic planning, financial management ,optimizing workflows, and fostering a culture of continuous improvement to ensure quality assurance and staff development. My expertise is grounded in a deep understanding of regulatory compliance, including ISO 15189:2022, CAP, JCI, GCAA and local UAE health authority guidelines. Experienced in managing Special lab technical departments eg. Hematology, Chemistry, Microbiology, Molecular, Immunology, Blood Bank and Serology Departments.

• Microbiology Unit: managing the microbiology unit,

Ø Monitoring external and internal quality control such as CAP PT, NIKAS EQC, IQC Plans.

Ø Blood Cultures using BACTEC, Bact/Alert machines, all types of Cultures.

Ø Mycology and fungal culture and identification using Lactophenol.

Ø  Antibiotics Susceptibility using API for identification, MICROSCAN and VITECK2 for bacterial identification and antibiotic susceptibility, antimicrobial resistance patterns identification.

Ø Gram stain, Z-N stain, Maintenance of organisms, wet mount examination.

Ø Detection and interpretation of T.B QUANTIFERON TEST using automated and semi-automated ELISA machines.

Ø Prepared Annual Antibiogram reflecting main microorganisms in wards and ICU with antibiotic sensitivity.

Ø Manage infection control hospital program and participating in antibiotic stewardship program.

Ø Conducting Infection control trainings including hand hygiene, PPE, biomedical waste management, management of needle stick injury, and spill management.

• Hematology Unit:

Ø Interpretation of CBC, Peripheral blood film examination.

Ø Hemoglobin Electrophoresis and HPLC, Bone Marrow aspirate and Bone marrow biopsy, routine coagulation tests, Blood grouping and matching using machines such as Beckman coulter, Sysmex, Mindray, Stago, Orthoworkstation, Biorad D10, Sebia Electrophoresis also I have strong experience in transfusion medicine and Blood donation campaigns.

• Immunology Unit: Including Reporting and monitoring of EQC program.

Ø Screening and reporting of ANA with Immunofluorescence.

Ø Detection of antibodies and a wide range of infectious disease antibodies using Verclia, Chorus, Alegria, ELISA machines.

Ø  Food Intolerance tests and Allergy panels (by Immunoblot).

• Chemistry, Special chemistry, Serology and Hormones Unit:

Ø Running huge panels of routine and special tests including antiviral antibodies, hormones and interpretation of laboratory tests in collaboration with physicians.

Ø Using a lot of machines and techniques such as ROCHE (E411, C111, Integra 400, Cobas 6000), SIEMENS (Dimension, Advia Centaur), ABOTT (Arcitect), MINIVIDAS, BECKMAN, VITROS, Beckman Access machines etc.

Ø Interpretation of Double and Triple markers using Roche and Beckman softwares.

• Molecular Unit: which include detection of pathogens such as HCV, HIV, HBV, Covid19, Respiratory Panel, STDs, HPV panels, Gastrointestinal Panels, Thrombophilia, Factor II, V, MTHFR etc, using Real Time PCR, Thermocycler PCR and Microarray.

• Ibrahim NH, Elshazly AS, Ghareeb M, Elkhashab DM, Elnaggar GN. Role of miR-15b and miR-130b as Non-Invasive Biomarkers in Hepatocellular Carcinoma. Asian Pac J Cancer Prev. 2025 Jul 1;26(7):2479-2487.
• Radwan S, Kadry DY, Hamdy R, Kamel MM, Alsulami AS, Abdel-Moneim AS, Elkhashab DM. Molecular characterization and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in immunocompromised cancer patients. Int J Immunopathol Pharmacol. 2025 Jan-Dec;
• Mourad, Dalia F., Samah Radwan, Rana Hamdy, Dina M. ElKhashab, Mahmoud M. Kamel, Ahmed S. Abdel-Moneim, and Dalia Y. Kadry. 'Identification of Lower Respiratory Tract Pathogens in Cancer Patients: Insights into Fatal Outcomes.' Microorganisms 12, no. 8 (2024): 1686.
• Radwan, Samah, Dalia F. Mourad, Rana Hamdy, Mahmoud M. Kamel, Ahmed S. Abdel-Moneim, Dina M. ElKhashab, and Dalia Y. Kadry. 'Clinical Profiles, Laboratory Biomarkers, and Mortality in Cancer Patients with Lower Respiratory Tract Infections: A Prospective Cohort Study.' Medicina 60, no. 6 (2024): 901.
• Tawfik, Dina Ibrahim, Dina Mohamed ElKhashab, Rahma Kamalaledin Abou Elnour, Nabila Mostafa Kamal, Omayma Anwar Khorshid, and Marwa Nagi Mehesen. 'Possible renoprotective effect of valsartan/sacubitril versus valsartan and Metformin in rat model of diabetic nephropathy.' Journal of Advanced Pharmacy Education and Research 13, no. 1-2023 (2023): 51-61.
• El-Fiky, Abir A., Ahmed Eldousouky, And Dina M. ElKhashab. 'Effect of the Egyptian sahara sand viper venom on human breast cancer: an in vitro study.' Journal of the Egyptian Society of Parasitology 49, no. 3 (2019): 589-598